M. A. Hillman

Impact of age, CYP2C9 genotype and concomitant medication on the rate of rise for prothrombin time during the first 30 days of warfarin therapy.

M. Caldwell, R. Wilke, R. Berg, 2005, Clinical medicine & research.

Gene structure and expression study of the SEDL gene for spondyloepiphyseal dysplasia tarda.

J. Gécz, J. Mulley, T. Cox, 2000, Genomics.

Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype.

M. Caldwell, R. Wilke, R. Berg, 2004, Pharmacogenetics.

A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data.

M. Caldwell, R. Wilke, R. Berg, 2005, Clinical medicine & research.

Peripheral Neuropathy in Diabetic Monkeys

B. Hansen, D. Cornblath, J. Striffler, 1989, Diabetes.